Research programme: tuberculosis vaccine - CEL-SCI
Alternative Names: LEAPS-based TB vaccine - CEL-SCILatest Information Update: 27 Oct 2014
At a glance
- Originator CEL-SCI Corporation
- Class Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Tuberculosis
Most Recent Events
- 04 Apr 2013 Discontinued - Preclinical for Tuberculosis (Prevention) in USA (Parenteral)
- 04 Apr 2013 No development reported - Preclinical for Tuberculosis in USA (Parenteral)
- 05 Jun 2009 Preclinical trials in Tuberculosis in USA (Parenteral)